BIOCEPT INC Quarterly Weighted Average Number of Shares Outstanding, Diluted from Q1 2013 to Q2 2023

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Biocept Inc quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q1 2013 to Q2 2023.
  • Biocept Inc Weighted Average Number of Shares Outstanding, Diluted for the quarter ending June 30, 2023 was 1.04M shares, a 83.9% increase year-over-year.
  • Biocept Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 17M shares, a 14.7% increase from 2021.
  • Biocept Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 14.8M shares, a 24.7% increase from 2020.
  • Biocept Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2020 was 11.8M shares, a 473% increase from 2019.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2023 1.04M +473K +83.9% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-14
Q1 2023 17.6M +771K +4.57% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-10
Q4 2022 17M +2.18M +14.7% Oct 1, 2022 Dec 31, 2022 10-K 2023-04-17
Q3 2022 17M +1.61M +10.5% Jul 1, 2022 Sep 30, 2022 10-Q/A 2023-04-17
Q2 2022 564K -12.9M -95.8% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 16.8M +3.18M +23.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 14.8M +2.93M +24.7% Oct 1, 2021 Dec 31, 2021 10-K 2023-04-17
Q3 2021 15.4M +2.05M +15.4% Jul 1, 2021 Sep 30, 2021 10-Q/A 2023-04-17
Q2 2021 13.5M +745K +5.86% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-10
Q1 2021 13.7M +5.77M +73% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-23
Q4 2020 11.8M -17.3M -59.3% Oct 1, 2020 Dec 31, 2020 10-K 2022-04-05
Q3 2020 13.3M +11M +479% Jul 1, 2020 Sep 30, 2020 10-K 2022-04-05
Q2 2020 12.7M -7.75M -37.9% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 7.9M -1.89M -19.3% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-12
Q4 2019 29.1M +24.9M +592% Oct 1, 2019 Dec 31, 2019 10-K 2020-03-27
Q3 2019 2.3M -458K -16.6% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-16
Q2 2019 20.5M +18.2M +798% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-13
Q1 2019 9.79M +7.88M +412% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-14
Q4 2018 4.21M +3.15M +298% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-27
Q3 2018 2.76M +1.76M +177% Jul 1, 2018 Sep 30, 2018 10-K 2020-03-27
Q2 2018 2.28M +1.38M +153% Apr 1, 2018 Jun 30, 2018 10-K 2020-03-27
Q1 2018 1.91M +1.2M +170% Jan 1, 2018 Mar 31, 2018 10-K 2020-03-27
Q4 2017 1.06M -14.6M -93.2% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-29
Q3 2017 995K -7.38M -88.1% Jul 1, 2017 Sep 30, 2017 10-K 2019-03-29
Q2 2017 901K -6.8M -88.3% Apr 1, 2017 Jun 30, 2017 10-K 2019-03-29
Q1 2017 707K -5.86M -89.2% Jan 1, 2017 Mar 31, 2017 10-K 2019-03-29
Q4 2016 15.6M +9.31M +148% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-28
Q3 2016 8.37M +2.13M +34.1% Jul 1, 2016 Sep 30, 2016 10-K 2018-03-28
Q2 2016 7.7M +1.7M +28.3% Apr 1, 2016 Jun 30, 2016 10-K 2018-03-28
Q1 2016 6.57M +3.11M +89.9% Jan 1, 2016 Mar 31, 2016 10-K 2018-03-28
Q4 2015 6.31M +1.86M +41.8% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-28
Q3 2015 6.24M +1.79M +40.3% Jul 1, 2015 Sep 30, 2015 10-K 2017-03-28
Q2 2015 6.01M +1.56M +35% Apr 1, 2015 Jun 30, 2015 10-K 2017-03-28
Q1 2015 3.46M +840K +32.1% Jan 1, 2015 Mar 31, 2015 10-K 2017-03-28
Q4 2014 4.45M +4.27M +2342% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-10
Q3 2014 4.45M +4.27M +2345% Jul 1, 2014 Sep 30, 2014 10-K 2016-03-10
Q2 2014 4.45M +4.27M +2341% Apr 1, 2014 Jun 30, 2014 10-K 2016-03-10
Q1 2014 2.62M +2.44M +1350% Jan 1, 2014 Mar 31, 2014 10-K 2016-03-10
Q4 2013 182K Oct 1, 2013 Dec 31, 2013 10-K 2015-03-11
Q3 2013 182K Jul 1, 2013 Sep 30, 2013 10-K 2015-03-11
Q2 2013 182K Apr 1, 2013 Jun 30, 2013 10-K 2015-03-11
Q1 2013 181K Jan 1, 2013 Mar 31, 2013 10-K 2015-03-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.